Specipig
Versa Biomedical is a versatile preclinical Contract Research Organization (CRO) specializing in designing flexible ad hoc biomedical models for solid solutions. With over 12 years of experience, they support biomedical, pharmaceutical, biotechnology, and medical device companies through tailored preclinical services, including in vivo and in vitro testing, efficacy, safety, and biocompatibility studies. They operate state-of-the-art facilities, breed their own miniature pig models, and are committed to open innovation, quality standards, and sustainable development. Their mission is to drive scientific breakthroughs and facilitate the development of new therapies and medical devices, with a focus on safety, efficacy, and regulatory compliance.
Industries
Nr. of Employees
small (1-50)
Specipig
Products
Research miniature pig line (breeding supply)
A purpose-bred miniature pig line developed for preclinical research, supplied with housing and husbandry support compliant with applicable regulations.
Preclinical research facilities (surgical suites, NICU, analytical labs)
Turnkey access to operating rooms, NICU, analytical laboratories and recovery units to run complex preclinical protocols.
Research miniature pig line (breeding supply)
A purpose-bred miniature pig line developed for preclinical research, supplied with housing and husbandry support compliant with applicable regulations.
Preclinical research facilities (surgical suites, NICU, analytical labs)
Turnkey access to operating rooms, NICU, analytical laboratories and recovery units to run complex preclinical protocols.
Services
Consultancy and development of tailored swine models aligned to sponsor scientific questions and regulatory needs.
Conduct of PoC, efficacy, PK/PD, toxicology and safety studies in pig models with on-site surgical, imaging and laboratory support.
Verification, validation, biocompatibility (ISO 10993) and usability testing of medical devices in anatomically relevant large-animal models.
Design and execution of pharmacokinetic, toxicokinetic and pharmacodynamic studies including sample handling and laboratory analysis.
Preterm and neonatal preclinical studies conducted in a dedicated NICU environment with specialized equipment and monitoring.
Advisory service for study design, endpoint selection and protocol drafting including support for ethical and regulatory authorizations.
Consultancy and development of tailored swine models aligned to sponsor scientific questions and regulatory needs.
Conduct of PoC, efficacy, PK/PD, toxicology and safety studies in pig models with on-site surgical, imaging and laboratory support.
Verification, validation, biocompatibility (ISO 10993) and usability testing of medical devices in anatomically relevant large-animal models.
Design and execution of pharmacokinetic, toxicokinetic and pharmacodynamic studies including sample handling and laboratory analysis.
Preterm and neonatal preclinical studies conducted in a dedicated NICU environment with specialized equipment and monitoring.
Advisory service for study design, endpoint selection and protocol drafting including support for ethical and regulatory authorizations.
Expertise Areas
- Preclinical study design and execution
- Swine-based disease model development
- Pharmacokinetics and toxicology studies
- Medical device preclinical testing and biocompatibility
Key Technologies
- GLP-compliant study execution
- ISO 13485 quality management for medical device studies
- Endovascular surgical techniques in swine
- Multimodal MRI for longitudinal assessment
News & Updates
Versa Biomedical organized a sports event in Barcelona to promote health and well-being, aligned with SDG 3.
The company has established a NICU in Barcelona to support preclinical studies on neonatal and preterm health.
The company has increased its research capacity with new facilities in Barcelona.
The company has achieved ISO 13485 certification for medical devices, reinforcing its commitment to quality.
Versa Biomedical will participate in the major biotech event in Boston, showcasing its preclinical services.
The company has obtained ISO 13485 certification, demonstrating compliance with international standards for medical devices.
Versa Biomedical organized a sports event in Barcelona to promote health and well-being, aligned with SDG 3.
The company has established a NICU in Barcelona to support preclinical studies on neonatal and preterm health.
The company has increased its research capacity with new facilities in Barcelona.
The company has achieved ISO 13485 certification for medical devices, reinforcing its commitment to quality.
Versa Biomedical will participate in the major biotech event in Boston, showcasing its preclinical services.
The company has obtained ISO 13485 certification, demonstrating compliance with international standards for medical devices.